We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
(+5.5%)
Cap. Flow
+$84.9M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$66.4M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$57.7M |
| 3 |
Amazon
AMZN
|
+$56.5M |
| 4 |
Advanced Micro Devices
AMD
|
+$37.5M |
| 5 |
Salesforce
CRM
|
+$35.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$122M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$60.8M |
| 3 |
Applied Materials
AMAT
|
+$43.7M |
| 4 |
Nu Holdings
NU
|
+$35.9M |
| 5 |
Incyte
INCY
|
+$32.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.8% |
| 2 | Healthcare | 28.54% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 7.84% |
| 5 | Industrials | 7.59% |
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2024 Portfolio in Review
As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
- Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
- Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
- Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
- Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
- Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
- Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.
Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.